UK tackles liver disease and hep C testing need
This article was originally published in Clinica
The UK government today announced plans to establish a liver disease strategy, and NHS clinicians are being reminded to be alert for undiagnosed cases of hepatitis C (HCV), in the run-up to a public awareness campaign that aims to increase early testing and diagnosis rates.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.